 "Maharashtra to get 435,000 Remdesivir vials by month-end from Centre")
Maharashtra Chief Minister Uddhav
Thackeray on Saturday said the state will get 4.35 lakh vials of Remdesivir for the period between April 21 to April 30 from the Centre.
He also thanked Prime Minister Narendra Modi for accepting the state's demand to increase the supply.
He had highlighted the need for more doses of the key medicine, used for the treatment of COVID-19, in the prime minister's interaction with chief ministers and also written to the PM separately on the issue, Thackeray said.
"The present supply was 2.69 lakh vialswhich has been increased to 4.35 lakh vials," he said.
The state government had received a letter from the Union health ministry that this supply of Remdesivir will be for the period between April 21 to April 30, he said.
Out of 16 lakh vials to be provided to the states during this period, Maharashtra will get 4.35 lakh, Thackeray said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app